Pfizer Income from Continuous Operations 2010-2024 | PFE

Pfizer income from continuous operations for the twelve months ending September 30, 2024 was $4.305B, a 59.03% decline year-over-year.

  • Pfizer annual income from continuous operations for 2023 was $2.172B, a 93.08% decline from 2022.
  • Pfizer annual income from continuous operations for 2022 was $31.401B, a 39.81% increase from 2021.
  • Pfizer annual income from continuous operations for 2021 was $22.459B, a 236.92% increase from 2020.

Pfizer Income from Continuous Operations 2010-2024 | PFE

  • Pfizer annual income from continuous operations for 2023 was $2.172B, a 93.08% decline from 2022.
  • Pfizer annual income from continuous operations for 2022 was $31.401B, a 39.81% increase from 2021.
  • Pfizer annual income from continuous operations for 2021 was $22.459B, a 236.92% increase from 2020.